---
title: "Helix Biotech Biosimilar mRNA Vaccines"
ocid: "ocds-h6vhtk-0585bd"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0585bd"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-0585bd.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-0585bd.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "UK HEALTH SECURITY AGENCY"
published: "2025-09-04"
---

# Helix Biotech Biosimilar mRNA Vaccines

Buyer: UK HEALTH SECURITY AGENCY  
Current stage: Award  
OCID: ocds-h6vhtk-0585bd

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0585bd)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-0585bd.json)

## Summary

The procurement process, led by the UK Health Security Agency, centred around the provision of biosimilar mRNA vaccines, specifically focusing on industry advancements in biotechnology. The buying organisation, a central government public authority, is located at 10 South Colonnade in London, United Kingdom. Initially, a direct award strategy was employed with Helix Biotech Inc., situated in Tennessee, USA. This direct procurement was chosen due to the unique capabilities of Helix Biotech in supplying vaccine mimic materials equivalent to existing licensed vaccines. The contract, awarded on 12th August 2025, is now in a completed status, although a tender cancellation notice was subsequently issued on 4th September 2025 to enable a revised transparency notice. The contract period is set from 8th September 2025 to 7th September 2027.

This tender represents a significant growth opportunity for businesses involved in the biosimilars and vaccine manufacturing sectors. Companies possessing innovative biotechnology solutions or those able to offer novel biopharmaceutical ingredients would find themselves particularly suited to compete in this sphere. Additionally, businesses with existing capabilities that include mRNA technology and lipid nanoparticle formulation are well positioned to take advantage of direct procurement methods employed by government entities, ensuring swift entry and operational benefits in this rapidly evolving industry. This contract underscores the potential for further collaborations with public health agencies looking to secure strategic resources aligned with contemporary health security needs.

## Notice

Vaccine mimic materials-comprising messenger RNA (mRNA) and lipid nanoparticles (LNPs)-from Helix-Biotech.

### Procurement Information

Helix-Biotech Inc. is the only supplier capable of delivering the required vaccine mimic materials (mRNA encapsulated in LNPs) with validated equivalence to licensed Pfizer-style COVID-19 vaccines. Their proprietary methodology and formulation capability are not available from other suppliers, nor covered under any current public procurement frameworks.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/053927-2025 |
| Notice type | UK5 - Transparency Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Direct |
| Procurement method details | Direct award |
| Tender suitability | SME, VCSE |
| Awardee scale | SME |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 4 Sep 2025 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 12 Aug 2025 |
| Contract period | 7 Sep 2025 - 7 Sep 2027 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | £150,000 |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Cancelled |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | UK HEALTH SECURITY AGENCY |
| Additional buyers | Missing |
| Locality | LONDON |
| Post town | East London |
| Postcode | E14 4PU |
| Country | England |
| ITL 1 | TLI London |
| ITL 2 | TLI4 Inner London - East |
| ITL 3 | TLI42 Tower Hamlets |
| Local authority | Tower Hamlets |
| Electoral ward | Canary Wharf |
| Westminster constituency | Poplar and Limehouse |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | HELIX BIOTECH |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33651600 - Vaccines

## Release History

- 4 Sep 2025 at 12:41 - TenderCancellation - UK12 - Procurement Termination Notice - https://www.find-tender.service.gov.uk/Notice/053927-2025
- 12 Aug 2025 at 09:18 - Award - UK5 - Transparency Notice - https://www.find-tender.service.gov.uk/Notice/047894-2025

## Documents

- https://www.find-tender.service.gov.uk/Notice/053927-2025
  4th September 2025 - Procurement termination notice on Find a Tender
- https://www.find-tender.service.gov.uk/Notice/047894-2025
  12th August 2025 - Transparency notice on Find a Tender

## Notice URLs

- https://www.gov.uk/government/organisations/uk-health-security-agency
- https://www.legislation.gov.uk/ukpga/2023/54/contents

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0585bd. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-0585bd.json.